Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1959 1
1975 1
1976 1
1977 2
1978 1
1982 1
1984 2
1988 2
1991 1
1999 1
2000 1
2001 3
2002 3
2003 4
2004 5
2005 1
2006 3
2007 3
2008 5
2009 5
2010 4
2011 5
2012 2
2013 5
2014 2
2015 3
2016 3
2017 6
2018 7
2019 6
2020 8
2021 7
2022 3
2023 6
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

94 results

Results by year

Filters applied: . Clear all
Page 1
The gut microbial metabolite, 3,4-dihydroxyphenylpropionic acid, alleviates hepatic ischemia/reperfusion injury via mitigation of macrophage pro-inflammatory activity in mice.
Li R, Xie L, Li L, Chen X, Yao T, Tian Y, Li Q, Wang K, Huang C, Li C, Li Y, Zhou H, Kaplowitz N, Jiang Y, Chen P. Li R, et al. Acta Pharm Sin B. 2022 Jan;12(1):182-196. doi: 10.1016/j.apsb.2021.05.029. Epub 2021 Jun 1. Acta Pharm Sin B. 2022. PMID: 35127379 Free PMC article.
Furthermore, 3,4-dihydroxyphenylpropionic acid suppressed the macrophage pro-inflammatory response in vivo and in vitro. ...Our findings revealed a novel protective microbial metabolite against HIRI in mice. The potential underlying mechanism was at le …
Furthermore, 3,4-dihydroxyphenylpropionic acid suppressed the macrophage pro-inflammatory response in vivo and i …
Prediagnostic plasma polyphenol concentrations and colon cancer risk: The JPHC nested case-control study.
Mori N, Murphy N, Sawada N, Achaintre D, Yamaji T, Scalbert A, Iwasaki M, Inoue M, Gunter MJ, Tsugane S. Mori N, et al. Clin Nutr. 2022 Sep;41(9):1950-1960. doi: 10.1016/j.clnu.2022.06.041. Epub 2022 Jul 8. Clin Nutr. 2022. PMID: 35952597
RESULTS: In sexes combined log2-transformed multivariable models, circulating levels of 3,4-dihydroxyphenylpropionic acid (P = 0.02), ferulic acid (P = 0.02), and caffeic acid (P = 0.03) were inversely, and 3-hydroxybenzoic acid (P = 0.03) was positive …
RESULTS: In sexes combined log2-transformed multivariable models, circulating levels of 3,4-dihydroxyphenylpropionic …
Sulfation of Phenolic Acids: Chemoenzymatic vs. Chemical Synthesis.
Kolaříková V, Brodsky K, Petrásková L, Pelantová H, Cvačka J, Havlíček L, Křen V, Valentová K. Kolaříková V, et al. Int J Mol Sci. 2022 Dec 2;23(23):15171. doi: 10.3390/ijms232315171. Int J Mol Sci. 2022. PMID: 36499496 Free PMC article.
Both approaches were tested with six selected phenolic acids (2-hydroxyphenylacetic acid (2-HPA), 3-hydroxyphenylacetic acid (3-HPA), 4-hydroxyphenylacetic acid (4-HPA), 3,4-dihydroxyphenylacetic acid (DHPA), 3-(4-hydroxyphenyl)propionic acid (4-HPP), and 3,4-dih …
Both approaches were tested with six selected phenolic acids (2-hydroxyphenylacetic acid (2-HPA), 3-hydroxyphenylacetic acid (3-HPA), 4-hydr …
Microscopic acid dissociation constants of 3,4-dihydroxyphenylpropionic acid and related compounds, and 3,4-dihydroxyphenylalanine (DOPA).
Ishimutsu T, Hirose S, Sakurai H. Ishimutsu T, et al. Talanta. 1977 Sep;24(9):555-60. doi: 10.1016/0039-9140(77)80049-0. Talanta. 1977. PMID: 18962144
The dissociation constants of 3,4-dihydroxyphenylpropionic acid and related compounds and of DOPA were determined by potentiometric titration and complementary tristimulus colorimetry at 25 degrees and mu = 0.1 (NaClO(4)) in aqueous solution. ...The mi …
The dissociation constants of 3,4-dihydroxyphenylpropionic acid and related compounds and of DOPA were determine …
Kinetics and mechanism of the reaction between chromium(III) and 3,4-dihydroxyphenylpropionic (dihydrocaffeic) acid in weak acidic aqueous solutions.
Petrou AL, Paraskevopoulou P, Chrysikopoulou M. Petrou AL, et al. J Inorg Biochem. 2004 Jan;98(1):123-32. doi: 10.1016/j.jinorgbio.2003.09.008. J Inorg Biochem. 2004. PMID: 14659641
The reaction of 3,4-dihydroxyphenylpropionic acid (dihydrocaffeic acid, hydcafH3) with chromium(III) in weak acidic aqueous solutions has been shown to take place through various oxygen-bonded intermediates. ...
The reaction of 3,4-dihydroxyphenylpropionic acid (dihydrocaffeic acid, hydcafH3) with chromium(III) in weak aci …
Kinetic cooperativity of tyrosinase. A general mechanism.
Muñoz-Muñoz JL, Garcia-Molina F, Varon R, Tudela J, Garcia-Cánovas F, Rodríguez-López JN. Muñoz-Muñoz JL, et al. Acta Biochim Pol. 2011;58(3):303-11. Epub 2011 Aug 29. Acta Biochim Pol. 2011. PMID: 21887411
This model can be generalised to a wide range of substrates; for example, type S(A) substrates, which give rise to a stable product as the o-quinone evolves by means of a first or pseudo first order reaction (alpha-methyl dopa, dopa methyl ester, dopamine, 3,4-di …
This model can be generalised to a wide range of substrates; for example, type S(A) substrates, which give rise to a stable product as the o …
Human Cancer Cell Membrane-Cloaked Fe3O4 Nanocubes for Homologous Targeting Improvement.
Zhang L, Xu H, Cheng Z, Wei Y, Sun R, Liang Z, Hu Y, Zhao L, Lian X, Li X, Huang D. Zhang L, et al. J Phys Chem B. 2021 Jul 15;125(27):7417-7426. doi: 10.1021/acs.jpcb.1c04383. Epub 2021 Jun 29. J Phys Chem B. 2021. PMID: 34185527
In this study, oleic acid (OA)-coated Fe(3)O(4) nanocubes were prepared by a high-temperature thermal decomposition method and modified by 3, 4-dihydroxyphenylpropionic acid (DHCA); then, HeLa cell membranes were introduced onto the surface of the nano …
In this study, oleic acid (OA)-coated Fe(3)O(4) nanocubes were prepared by a high-temperature thermal decomposition method and modified by …
Urinary metabolomics of phenolic compounds reveals biomarkers of type-2 diabetes within the PREDIMED trial.
Domínguez-López I, Lozano-Castellón J, Vallverdú-Queralt A, Jáuregui O, Martínez-González MÁ, Hu FB, Fitó M, Ros E, Estruch R, Lamuela-Raventós RM. Domínguez-López I, et al. Biomed Pharmacother. 2023 Jun;162:114703. doi: 10.1016/j.biopha.2023.114703. Epub 2023 Apr 14. Biomed Pharmacother. 2023. PMID: 37062219 Free article. Clinical Trial.
94 results